DAIC

JUNE 4, 2024

milla1cf Tue, 06/04/2024 - 20:54 June 4, 2024 — HeartFlow, a leader in cardiovascular healthcare technology, is pleased to announce a key Medicare policy development, which should allow for future expanded patient access to their Plaque Analysis product.

Medicare 104

Medicare Plaque Reimbursement Technology 104

DAIC

JUNE 18, 2024

The designation recognizes the novelty of the technology and the potential to provide a more effective treatment option for patients with coronary artery disease. 1 To date, interventional treatment of coronary artery disease with drug-eluting stents has been able to establish flow angiographically. of the U.S. population.

Coronary Artery Disease 105

Coronary Artery Disease Technology Stents Stent 105

DAIC

JULY 9, 2024

He completed his postgraduate training in cardiovascular disease and nuclear cardiology at Emory School of Medicine and is board certified in internal medicine and cardiovascular disease. He received his bachelor’s degree from Harvard University and his medical degree from Washington University in St. Louis, Missouri.

Innovation 111

Innovation Health Disparities Cardiovascular Disease Medicaid 111

DAIC

JULY 18, 2024

CPT codes are widely used by government payers, including Medicare and Medicaid, and commercial insurance companies to identify healthcare services and procedures for reimbursement. In accordance with the AMA semi-annual early release schedule, the new codes will be effective January 1st, 2025 and published in the 2025 CPT Code book.

Reimbursement 105

Reimbursement Technology Electrocardiogram Medicaid 105